Osaka, Japan

Hidenori Mikamiyama

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 87(Granted Patents)


Location History:

  • Toyonaka, JP (2015)
  • Osaka, JP (2006 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Journey of Hidenori Mikamiyama

Introduction

Hidenori Mikamiyama, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of antiviral compounds with a particular focus on influenza viruses. With a remarkable portfolio of 14 patents, he has dedicated his career to the development of innovative solutions for pressing health challenges.

Latest Patents

Among his latest inventions, Hidenori has introduced the "Substituted polycyclic carbamoyl pyridone derivative prodrug". This groundbreaking compound exhibits antiviral effects, especially demonstrating growth inhibitory activity on influenza viruses. A preferred example from his patents is the substituted 3-hydroxy-4-pyridone derivative prodrug that possesses cap-dependent endonuclease inhibitory activity. Additionally, he has developed a similar invention, the "Substituted polycyclic carbamolypyridone derivative," which also targets influenza viruses, specifically providing enhanced activity through substituted 3-hydroxy-4-pyridone derivatives with cap-dependent endonuclease inhibition.

Career Highlights

Hidenori Mikamiyama's career includes pivotal roles at prominent pharmaceutical companies. He worked with Shionogi & Company Limited and Purdue Pharma L.P., where he collaborated with many exceptional professionals to advance his research on antiviral compounds. His work reflects a commitment to scientific excellence and innovation, propelling forward the treatment options available for viral infections.

Collaborations

Throughout his career, Hidenori has had the opportunity to collaborate with esteemed colleagues, including Yoshiyuki Taoda and Toshiyuki Akiyama. These professional relationships have fostered many fruitful discussions and have likely contributed to the advancement of his innovative ideas and patent developments.

Conclusion

Hidenori Mikamiyama stands out as a key figure in the field of antiviral research, particularly in combating influenza viruses through novel chemical compounds. His impressive array of patents and collaborations with leading companies and researchers showcases his dedication to improving global health outcomes through innovation. His ongoing contributions continue to inspire and drive progress in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…